Description

Riboxin-Darnitsa (inosine) Coated Tablets 200 mg. №50

Ingredients

Active ingredient: Inosine 200 mg per tablet.

Dosage

Recommended dosage: The usual dose is 1-2 tablets three times a day. Consult a healthcare professional for personalized dosing.

Indications

Riboxin-Darnitsa tablets are indicated for the treatment of various heart conditions, liver disorders, and muscle diseases.

Contraindications

Do not use Riboxin-Darnitsa tablets if you are allergic to inosine or any other ingredients in the product.

Directions

Take Riboxin-Darnitsa tablets as directed by your healthcare provider. Swallow the tablets whole with water, preferably after meals.

Scientific Evidence

Riboxin-Darnitsa (inosine) has been studied for its effects on improving cellular energy metabolism. Research suggests that inosine may enhance ATP production, which is crucial for various physiological processes in the body.

Additional Information

It is important to note that individual responses to Riboxin-Darnitsa tablets may vary. Always follow your healthcare provider’s instructions for the best results.

Inosine, the active ingredient in Riboxin-Darnitsa tablets, plays a vital role in the synthesis of ATP, the primary energy carrier in cells. By increasing ATP levels, inosine may help improve energy production in tissues with high energy demands, such as the heart and skeletal muscles.

Clinical trials have shown promising results regarding the use of inosine in various conditions, including heart failure and muscle disorders. A study published in the Journal of Cardiac Failure demonstrated that inosine supplementation improved exercise capacity and quality of life in patients with heart failure.